Molecular Alterations in Intraductal Carcinoma of the Prostate.
cribriform prostate cancer
intraductal carcinoma of the prostate
intraductal proliferation
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
22 Nov 2023
22 Nov 2023
Historique:
received:
29
10
2023
revised:
17
11
2023
accepted:
20
11
2023
medline:
9
12
2023
pubmed:
9
12
2023
entrez:
9
12
2023
Statut:
epublish
Résumé
Intraductal carcinoma of the prostate is most commonly associated with high-grade invasive prostate cancer. However, isolated IDC-P without adjacent cancer or high-grade cancer is also well known. Common genetic alterations present in IDC-P with adjacent high-grade prostate cancer are those described in high-grade tumors, such as PTEN loss (69-84%). In addition, the rate of LOH involving
Identifiants
pubmed: 38067216
pii: cancers15235512
doi: 10.3390/cancers15235512
pmc: PMC10705183
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Nat Rev Urol. 2018 Apr;15(4):222-234
pubmed: 29460925
Pathology. 2018 Jan;50(1):60-73
pubmed: 29199015
Int J Surg Pathol. 2023 Apr;31(2):184-189
pubmed: 35521917
Cancers (Basel). 2022 Feb 06;14(3):
pubmed: 35159086
Am J Surg Pathol. 2010 Apr;34(4):478-85
pubmed: 20220513
Adv Anat Pathol. 2012 Jul;19(4):270-8
pubmed: 22692290
Int J Surg Pathol. 2020 Dec;28(8):918-924
pubmed: 32456482
J Clin Pathol. 2016 Oct;69(10):852-7
pubmed: 26926101
Nat Commun. 2022 Oct 13;13(1):6036
pubmed: 36229464
Mod Pathol. 2013 Apr;26(4):587-603
pubmed: 23222491
Semin Reprod Med. 2009 Sep;27(5):351-7
pubmed: 19711245
Mol Cancer Res. 2019 Feb;17(2):446-456
pubmed: 30333152
J Pathol. 2018 Apr;244(4):389-393
pubmed: 29377129
Eur Urol Focus. 2021 Sep;7(5):955-963
pubmed: 33132109
BMC Cancer. 2018 Jan 2;18(1):8
pubmed: 29295717
F1000Res. 2018 Aug 2;7:
pubmed: 30135717
Prostate. 2022 Aug;82 Suppl 1:S3-S12
pubmed: 35657157
Arch Pathol Lab Med. 2007 Jul;131(7):1103-9
pubmed: 17616999
J Urol. 2010 Oct;184(4):1328-33
pubmed: 20723921
J Pathol. 2019 Sep;249(1):79-89
pubmed: 30993692
Yonsei Med J. 2016 Sep;57(5):1054-62
pubmed: 27401634
Eur Urol. 2001 Apr;39 Suppl 4:4
pubmed: 11340276
Histopathology. 2022 Jun;80(7):1038-1040
pubmed: 35592932
Eur Urol. 2017 Nov;72(5):665-674
pubmed: 28511883
J Pathol. 2020 Apr;250(5):510-517
pubmed: 32057098
Neoplasia. 2021 Jun;23(6):634-641
pubmed: 34107378
Eur J Cancer. 2021 Apr;147:74-83
pubmed: 33626496
J BUON. 2021 May-Jun;26(3):728-733
pubmed: 34268927
Genes Chromosomes Cancer. 2008 Jul;47(7):565-72
pubmed: 18383208
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2518-26
pubmed: 24966964
Front Oncol. 2023 Jan 30;13:1115241
pubmed: 36793600
Am J Clin Exp Urol. 2022 Jun 15;10(3):170-179
pubmed: 35874287
Histopathology. 2021 Dec;79(6):1061-1071
pubmed: 34324714
Cell. 2015 Nov 5;163(4):1011-25
pubmed: 26544944
BMC Med. 2022 Jul 22;20(1):237
pubmed: 35864546
Prostate. 2019 Aug;79(11):1267-1273
pubmed: 31111513
Eur Urol. 2015 Mar;67(3):496-503
pubmed: 25154392
Science. 2005 Oct 28;310(5748):644-8
pubmed: 16254181
Prostate. 2018 Apr;78(5):401-407
pubmed: 29368341
Prostate. 2019 Jun;79(8):819-825
pubmed: 30900303
Nat Genet. 2013 Nov;45(11):1392-8
pubmed: 24076601
Histopathology. 2017 Nov;71(5):693-702
pubmed: 28570007
Lancet. 2021 Jul 10;398(10295):131-142
pubmed: 34246347
Am J Surg Pathol. 2015 Feb;39(2):169-78
pubmed: 25517949
Cancers (Basel). 2022 Nov 15;14(22):
pubmed: 36428706
Cells. 2020 Oct 22;9(11):
pubmed: 33105713
Pathol Res Pract. 2018 May;214(5):612-618
pubmed: 29628124
N Engl J Med. 2016 Aug 4;375(5):443-53
pubmed: 27433846
Eur Urol. 2015 May;67(5):819-22
pubmed: 25246081
Int J Mol Sci. 2021 Dec 04;22(23):
pubmed: 34884926
Cancer Res. 2023 Oct 17;:
pubmed: 37847513